Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- MENS
- Price
- 1.71
- Stock movement up
- +0.16 (10.32%)
- Company name
- Jyong Biotech Ltd. Ordinary Shares
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 130.01M
- Ent value
- 190.02M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-02-19
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
MENS does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 76.03M |
| EPS (TTM) | -0.02 |
| FCF per share (TTM) | -0.05 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -120.00K |
| Operating income (TTM) | -817.58K |
| Net income (TTM) | -1.25M |
| EPS (TTM) | -0.02 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 135.00K |
| Net receivables | 0.00 |
| Total current assets | 17.16M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 37.67M |
| Accounts payable | 3.00K |
| Short/Current long term debt | 35.19M |
| Total current liabilities | 27.55M |
| Total liabilities | 60.14M |
| Shareholder's equity | -22.47M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -3.62M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -3.62M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -3.33% |
| Return on Invested Capital | -282.51% |
| Cash Return on Invested Capital | -816.31% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.56 |
| Daily high | 1.80 |
| Daily low | 1.50 |
| Daily Volume | 430K |
| All-time high | 60.80 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | -0.02 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MENS | S&P500 | |
| Current price drop from All-time high | -97.19% | -1.82% |
| Highest price drop | -97.60% | -56.47% |
| Date of highest drop | 11 Feb 2026 | 9 Mar 2009 |
| Avg drop from high | -56.12% | -10.84% |
| Avg time to new high | 13 days | 12 days |
| Max time to new high | 78 days | 1805 days |
COMPANY DETAILS
Marketcap
130.01M
Marketcap category
Small-cap
Description
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner